Additional inborn errors of IL-6 family cytokines/receptors
| Genetic defect | IL6ST | IL11RA | LIFR | OSM | OSMRa | IL31RAa | IL27RA |
|---|---|---|---|---|---|---|---|
| Inheritance | AR complete | AR | AR | AR | AD | AD | AR |
| Core syndrome | SWS | Craniosynostosis/dental abnormalities | SWS | Severe bone marrow failure | FPLCA | FPLCA | EBV susceptibility |
| Main clinical lesson | IL-6ST/gp130 is essential for skeletal/autonomic development | IL-11 controls craniofacial/dental development | LIFR is essential for skeletal/autonomic development | OSM supports hematopoiesis/bone marrow niche | OSMRβ skin axis implicated in pruritic amyloidosis | IL-31RA skin axis implicated in pruritic amyloidosis | IL-27 is nonredundant in anti-EBV immunity |
| Skin and pulmonary infections | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not prominent |
| Atopic dermatitis/eczema | +/− | Not reported | Not reported | Not reported | ± association reported | Not reported | Not reported |
| Extrahematopoietic/developmental abnormalities | Skeletal dysplasia/neonatal lung dysfunction | Craniosynostosis, dental abnormalities | Skeletal dysplasia, pulmonary dysfunction, dysautonomia, urinary tract malformation | Not reported | Skin-limited amyloidosis; eosinophilic material in the skin | Skin-limited amyloidosis | Not reported |
| Hyper-IgE | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Eosinophilia | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Low memory B cells | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | + |
| Low Th17 cells | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | − |
| Impaired acute-phase/inflammatory responses | + | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Impaired IL-6 signaling | + | − | ND | ND | ND | ND | − |
| Impaired IL-11 signaling | + | + | ND | ND | ND | ND | ND |
| Impaired LIF signaling | + | − | + | ND | ND | ND | ND |
| Impaired OSM signaling | + | − | ND | + (ligand absent) | +/− | ND/not expected | ND |
| Impaired IL-31 signaling | ND | ND | ND | ND | +/− | ND/possibly affected in skin | ND |
| Impaired IL-27 signaling | + | − | ND | ND | ND | ND | + |
| Predominant compartment | Skeletal/mesenchymal | Craniofacial/mesenchymal | Skeletal/autonomic/mesenchymal | Hematopoietic niche | Skin/epithelial-stromal | Skin/epithelial-stromal | T cell anti-EBV immunity |
| Key references | (23) | (6, 20, 21) | (22) | (25) | (26, 27, 28) | (27) | (24) |
| Genetic defect | |||||||
|---|---|---|---|---|---|---|---|
| Inheritance | AR complete | AR | AR | AR | AD | AD | AR |
| Core syndrome | SWS | Craniosynostosis/dental abnormalities | SWS | Severe bone marrow failure | FPLCA | FPLCA | EBV susceptibility |
| Main clinical lesson | IL-6ST/gp130 is essential for skeletal/autonomic development | IL-11 controls craniofacial/dental development | LIFR is essential for skeletal/autonomic development | OSM supports hematopoiesis/bone marrow niche | OSMRβ skin axis implicated in pruritic amyloidosis | IL-31RA skin axis implicated in pruritic amyloidosis | IL-27 is nonredundant in anti-EBV immunity |
| Skin and pulmonary infections | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not prominent |
| Atopic dermatitis/eczema | +/− | Not reported | Not reported | Not reported | ± association reported | Not reported | Not reported |
| Extrahematopoietic/developmental abnormalities | Skeletal dysplasia/neonatal lung dysfunction | Craniosynostosis, dental abnormalities | Skeletal dysplasia, pulmonary dysfunction, dysautonomia, urinary tract malformation | Not reported | Skin-limited amyloidosis; eosinophilic material in the skin | Skin-limited amyloidosis | Not reported |
| Hyper-IgE | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Eosinophilia | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Low memory B cells | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | + |
| Low Th17 cells | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | − |
| Impaired acute-phase/inflammatory responses | + | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Impaired IL-6 signaling | + | − | ND | ND | ND | ND | − |
| Impaired IL-11 signaling | + | + | ND | ND | ND | ND | ND |
| Impaired LIF signaling | + | − | + | ND | ND | ND | ND |
| Impaired OSM signaling | + | − | ND | + (ligand absent) | +/− | ND/not expected | ND |
| Impaired IL-31 signaling | ND | ND | ND | ND | +/− | ND/possibly affected in skin | ND |
| Impaired IL-27 signaling | + | − | ND | ND | ND | ND | + |
| Predominant compartment | Skeletal/mesenchymal | Craniofacial/mesenchymal | Skeletal/autonomic/mesenchymal | Hematopoietic niche | Skin/epithelial-stromal | Skin/epithelial-stromal | T cell anti-EBV immunity |
| Key references | ( | ( | ( | ( | ( | ( | ( |
AD, autosomal dominant; AR, autosomal recessive; SWS, Stüve–Wiedemann syndrome; FPLCA, familial primary localized cutaneous amyloidosis; EBV, Epstein-Barr virus; ND, not determined.
OSMR and IL31RA variants have been reported in the heterozygous state in patients with FPLCA, their functional consequences appear context- and variant-dependent and remain incompletely defined.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.